Company: BDRX
Filing Date: 2025-04-29
Form Type: POS AM
Source: 0001214659-25-006581
Chunk: 135

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-04-29
Form: POS AM
Chunk 135
---
 the Company’s Report on Form 6-K, filed with the SEC on July 19, 2024).                                                                                                                                                                                                                                   |
| 4.22   | Form of Pre-Funded Warrant (incorporated by reference to Exhibit 4.4 of the Company’s Report on Form 6-K, filed with the SEC on July 19, 2024).                                                                                                                                                                                                                                                  |
| 5.1    | Opinion of Brown Rudnick (incorporated by reference to Exhibit 5.1 of the Company’s Registration Statement on Form F-1, filed with the SEC on January 17, 2024).                                                                                                                                                                                                                                 |
| 10.1

#  | Biodexa PLC Enterprise Management Incentive and Unapproved Share Option Scheme (incorporated by reference to Exhibit 4.1 to the Company’s Annual Report on Form 20-F for the year ended December 31, 2023, filed with the SEC on April 19, 2024).                                                                                                                                                |
| 10.2

#  | Form of Option Agreement (included in Exhibit 10.1).                                                                                                                                                                                                                                                                                                                                             |
| 10.3

#  | Form of Appointment Letter between Midatech Pharma PLC and certain directors of Midatech Pharma PLC (incorporated by reference to Exhibit 10.22 to the Company’s Registration Statement on Form F-4 (File No. 333-206305), originally filed with the SEC on August 11, 2015, as amended).                                                                                                        |
| 10.4

#  | Deed of Indemnity dated August 5, 2015 (incorporated by reference to Exhibit 10.23 to the Company’s Registration Statement on Form F-4 (File No. 333-206305), originally filed with the SEC on August 11, 2015, as amended).                                                                                                                                                                     |
| 10.5†  | License, Collaboration and Distribution Agreement, dated as of January 29, 2019, by and between Midatech Pharma PLC, CMS Bridging Limited, CMS Medical Hong Kong Limited and China Medical System Holdings Limited (incorporated by reference to Exhibit 4.17 of the Company’s Annual Report on Form 20-F for the year ended December 31, 2018, as amended, filed with the SEC on May 28, 2019). |
| 10.6†

# | Service Agreement dated as of September